The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders

被引:34
|
作者
Reif, Sharon [1 ]
Brolin, Mary F. [1 ]
Stewart, Maureen T. [1 ]
Fuchs, Thomas J. [3 ]
Speaker, Elizabeth [2 ]
Mazel, Shayna B. [1 ]
机构
[1] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA
[2] Washington State Dept Social & Hlth Serv, Res & Data Anal, 1115 Washington St,POB 4520, Olympia, WA 98504 USA
[3] Washington State Hlth Care Author, Div Behav Hlth & Recovery, 626 8th Ave SE,POB 45330, Olympia, WA 98504 USA
基金
美国国家卫生研究院;
关键词
SUBSTANCE USE DISORDERS; ASSISTED TREATMENT; BUPRENORPHINE-NALOXONE; COLLABORATIVE CARE; TREATMENT PROGRAMS; VERMONT HUB; IMPLEMENTATION; BARRIERS; PHYSICIANS; PHARMACOTHERAPY;
D O I
10.1016/j.jsat.2019.07.007
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: The federal Opioid State Targeted Response (Opioid STR) grants provided funding to each state to ramp up the range of responses to reverse the ongoing opioid crisis in the U.S. Washington State used these funds to develop and implement an integrated care model to expand access to medication treatment and reduce unmet need for people with opioid use disorders (OUD), regardless of how they enter the treatment system. This paper examines the design, early implementation and results of the Washington State Hub and Spoke Model. Methods: Descriptive data were gathered from key informants, document review, and aggregate data reported by hubs and spokes to Washington State's Opioid STR team. Results: The Washington State Hub and Spoke Model reflects a flexible approach that incorporates primary care and substance use treatment programs, as well as outreach, referral and social service organizations, and a nurse care manager. Hubs could be any type of program that had the required expertise and capacity to lead their network in medication treatment for OUD, including all three FDA-approved medications. Six hub-spoke networks were funded, with 8 unique agencies on average, and multiple sites. About 150 prescribers are in these networks (25 on average). In the first 18 months, nearly 5000 people were inducted onto OUD medication treatment: 73% on buprenorphine, 19% on methadone, and 9% on naltrexone. Conclusions: The Washington State Hub and Spoke Model built on prior approaches to improve the delivery system for OUD medication treatment and support services, by increasing integration of care, ensuring "no wrong door," engaging with community agencies, and supporting providers who are offering medication treatment. It used essential elements from existing integrated care OUD treatment models, but allowed for organic restructuring to meet the population needs within a community. To date, there have been challenges and successes, but with this approach, Washington State has provided medication treatment for OUD to nearly 5000 people. Sustainability efforts are underway. In the face of the ongoing opioid crisis, it remains essential to develop, implement and evaluate novel models, such as Washington's Hub and Spoke approach, to improve treatment access and increase capacity.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [1] Expanding access to medication treatment for opioid use disorders: Findings from the Washington State hub and spoke effort
    Stewart, Maureen T.
    Daily, Shay M.
    Thomas, Cindy Parks
    Panas, Lee
    Ritter, Grant
    Reif, Sharon
    DRUG AND ALCOHOL DEPENDENCE, 2024, 256
  • [2] Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system
    Rawson, Richard A.
    Rieckmann, Traci
    Cousins, Sarah
    McCann, Michael
    Pearce, Regina
    PREVENTIVE MEDICINE, 2019, 128
  • [3] Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact
    Miele, Gloria M.
    Caton, Lauren
    Freese, Thomas E.
    McGovern, Mark
    Darfler, Kendall
    Antonini, Valerie Pearce
    Perez, Marlies
    Rawson, Richard
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 108 : 20 - 25
  • [4] Barriers for Implementing the Hub and Spoke Model to Expand Medication for Opioid Use Disorder: A Case Study of Montana
    Green, Brandn
    Rhubart, Danielle Christine
    Filteau, Matthew R.
    SUBSTANCE ABUSE-RESEARCH AND TREATMENT, 2021, 15
  • [5] Implementation of a Hub-and-Spoke Partnership for Opioid Use Disorder Treatment in a Medicaid Nonexpansion State
    Marcovitz, David E.
    Pettapiece-Phillips, Mariah
    Kast, Kristopher A.
    White, Katie
    Himelhoch, Heather
    Audet, Carolyn
    PSYCHIATRIC SERVICES, 2022, 73 (07) : 819 - 822
  • [6] Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system
    Rawson, Richard
    Cousins, Sarah J.
    McCann, Michael
    Pearce, Regina
    Van Donsel, Anne
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 97 : 84 - 90
  • [7] State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder
    Abraham, Amanda J.
    Andrews, Christina M.
    Grogan, Colleen M.
    Pollack, Harold A.
    D'Aunno, Thomas
    Humphreys, Keith
    Friedmann, Peter D.
    PSYCHIATRIC SERVICES, 2018, 69 (04) : 448 - 455
  • [8] (RE-)AIMing for Rapid Uptake Pilot Evaluation of a Modified Hub and Spoke Model of Medication for Opioid Use Disorder
    Heavey, Sarah Cercone
    Beehler, Gregory P.
    Funderburk, Jennifer
    MEDICAL CARE, 2024, 62 (01) : 44 - 51
  • [9] Role of Medication in the Treatment of Opioid Use Disorders
    Baird, Carolyn
    JOURNAL OF ADDICTIONS NURSING, 2015, 26 (04) : 213 - 216
  • [10] Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities
    Mojtabai, Ramin
    Mauro, Christine
    Wall, Melanie M.
    Barry, Colleen L.
    Olfson, Mark
    HEALTH AFFAIRS, 2019, 38 (01) : 14 - 23